Table 3C. Multivariable analyses of muscle mass and metabolite associations in all participants.
All | Q1 | Q4 | P | Parameter Estimate (SE) Before Adjustment | Parameter Estimate (SE) After Adjustment | Multivariable –Stepwise |
(N=76) | (N=77) | (Q1 vs Q4) | P-value | |||
Age, yrs | 80.24±7.96 | 83.14±6.81 | 0.3969 | 0.0532 (0.0225) | NA | |
Glu, μM | 62.49±29.36 | 42.76±14.15 | 6.65E-07 | -0.0413 (0.0093) | -0.0440 (0.0102) | 4.07E-05 |
Cit/Orn | 0.29±0.09 | 0.37±0.12 | 4.82E-05 | 7.1674 (1.9484) | 6.7456 (2.1960) | 0.0021 |
DOPA, μM | 0.17±0.05 | 0.17±0.04 | 0.2747 | 3.9774 (3.6411) | 9.8519 (4.6787) | 0.0352 |
alpha_AAA, μM | 0.99±0.34 | 0.78±0.24 | 2.56E-05 | -2.6296 (0.6673) | NA |
Data are mean ± SD. SE: Standard Error. Variables were analyzed by independent samples t-tests or Chi-square test (age). Multiple logistic regression models were used to analyze the effect of gender on the dependent variable controlling for age and comorbidities, including hypertension, diabetes, hyperlipidemia, coronary artery disease (CAD), cancer, stroke, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and osteoporosis. Model significance was presented in adjusted P-value.